Get 40% Off
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Jim Cramer Is 'A Seller' Of This Company Because 'Elon Musk Said That He Doesn't Like That Business'

Published 11/10/2023, 13:51
Updated 11/10/2023, 15:10
© Reuters.  Jim Cramer Is 'A Seller' Of This Company Because 'Elon Musk Said That He Doesn't Like That Business'
ABT
-

Benzinga - by Priya Nigam, Benzinga Staff Writer.

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Abbott Laboratories (NYSE: ABT) is a "very good company and will be up to the—let’s say—up to the challenge. I think that’s fair. You’re getting a premium company at a very low multiple that is doing a lot right."

When asked about Herbalife Ltd. (NYSE: HLF), he said, "That ship has sailed, frankly, I’m moving on from that one." The company’s stock has lost more than 9% over the past six months.

Cramer said he prefers Honeywell International Inc. (NYSE: HON) over Spirit AeroSystems Holdings, Inc. (NYSE: SPR).

"Let’s just stick away from CVS Health Corporation (NYSE: CVS)," Cramer said.

Don’t forget to check out our premarket coverage here

When asked about Albemarle Corporation (NYSE: ALB), he said, "I’m a seller because Elon Musk said that he doesn’t like that business. And I’m not going against Elon no matter what."

The "Mad Money" host said Viking Therapeutics, Inc. (NASDAQ: VKTX) is a "very good spec, but you have to understand it could be wiped out or go up a lot."

Price Action: Shares of Viking fell 1.8% to close at $11.35, while Albemarle gained 4.1% to $162.08 on Tuesday. CVS rose 0.7% to settle at $71.73, while Honeywell slipped 0.1% to close at $186.34 on Tuesday. Spirit AeroSystems shares climbed 4.9% to close at $17.61, while Herbalife rose 1.5% to settle at $13.94 on Tuesday. Shares of Abbott added 0.8% to close at $97.56 on Tuesday.

Now Read This: Intuit, Nordstrom And 2 Other Stocks Insiders Are Selling

Photo: Shutterstock

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.